According to MiMedx Group's latest financial reports the company has a price-to-book ratio of 7.48.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 8.99 | -151.2% |
2022-12-31 | -17.6 | -100.21% |
2021-12-31 | > 1000 | -222.89% |
2020-12-31 | < -1000 | -27642.37% |
2019-12-31 | 24.4 | 509.74% |
2018-12-31 | 4.00 | -78.9% |
2017-12-31 | 19.0 | 160.06% |
2016-12-31 | 7.30 | -21.69% |
2015-12-31 | 9.32 | -33.04% |
2014-12-31 | 13.9 | 12.2% |
2013-12-31 | 12.4 | -26.89% |
2012-12-31 | 17.0 | 140.47% |
2011-12-31 | 7.05 | -50.45% |
2010-12-31 | 14.2 | -1.78% |
2009-12-31 | 14.5 | -63.31% |
2008-12-31 | 39.5 | |
2007-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Medtronic MDT | 2.19 | -70.76% | ๐ฎ๐ช Ireland |
Teleflex TFX | 2.32 | -69.00% | ๐บ๐ธ USA |
Steris STE | 3.55 | -52.57% | ๐ฎ๐ช Ireland |
NuVasive NUVA | 2.34 | -68.76% | ๐บ๐ธ USA |